Trial record 1 of 501 for:    Open Studies | "Pulmonary Disease, Chronic Obstructive"
Previous Study | Return to List | Next Study

Mindfulness-based Cognitive Therapy for Chronic Obstructive Pulmonary Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by University of Aarhus
Sponsor:
Collaborator:
Aarhus University Hospital
Information provided by (Responsible Party):
University of Aarhus
ClinicalTrials.gov Identifier:
NCT02042976
First received: January 17, 2014
Last updated: February 3, 2014
Last verified: February 2014
  Purpose

The purpose of the study is to determine the efficacy of mindfulness-based cognitive therapy (MBCT) as an add-on to pulmonary rehabilitation (treatment as usual, TAU) in chronic obstructive pulmonary disease (COPD).

The investigators hypothesize that compared to treatment-as-usual, the add-on of MBCT will result in improved psychological (anxiety, depression, QoL) and physical outcomes (physical health status, activity level). Furthermore, the investigators will explore the possible moderating role of individual differences in sociodemographic and disease-related characteristics and mediating role of self-efficacy and self-compassion for the hypothesised effect.


Condition Intervention
Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Lung Disease
Chronic Obstructive Airway Disease
Chronic Bronchitis
Emphysema
Behavioral: Mindfulness-based cognitive therapy
Behavioral: Pulmonary rehabilitation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Supportive Care
Official Title: A Randomised Controlled Trial of Mindfulness-based Cognitive Therapy (MBCT) for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Resource links provided by NLM:


Further study details as provided by University of Aarhus:

Primary Outcome Measures:
  • Change from baseline in health-related quality of life on the COPD Assessment Test (CAT) at week 8 [ Time Frame: Baseline, Week 8 ] [ Designated as safety issue: No ]
  • Change from baseline in anxiety and depression on the Hospital Anxiety and Depression Scale (HADS) at week 8 [ Time Frame: Baseline, Week 8 ] [ Designated as safety issue: No ]
  • Change from baseline in physical health status on the breathlessness-obstruction-dyspnea-exercise capacity (BODE) index at week 8 [ Time Frame: Baseline, Week 8 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change from baseline in physical activity at week 8 [ Time Frame: Baseline, Week 8 ] [ Designated as safety issue: No ]
    Measured by accelerometry


Estimated Enrollment: 120
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mindfulness-based cognitive therapy + pulmonary rehabilitation Behavioral: Mindfulness-based cognitive therapy Behavioral: Pulmonary rehabilitation
Active Comparator: Pulmonary rehabilitation only Behavioral: Pulmonary rehabilitation

Detailed Description:

Chronic obstructive pulmonary disease (COPD) is a major burden for the affected patients, who are continuously struggling with the hallmark symptoms breathlessness, cough, and sputum together with high levels of anxiety and depression and impairment of quality of life (QoL). The potential value of complementary interventions in COPD has long been recognised, yet so far, no overall significant effects of psychosocial intervention programs such as cognitive behavioural therapy or supportive/analytical psychotherapy have been found.

Mindfulness-based interventions have been shown to improve levels of physical symptoms, stress, anxiety, depression, and QoL in other chronic conditions, and could also be relevant in COPD. The present randomized controlled trial will test the efficacy of mindfulness-based cognitive therapy (MBCT) in COPD patients. The investigators hypothesize that compared to treatment-as-usual, the add-on of MBCT will result in improved psychological (anxiety, depression, QoL) and physical outcomes (physical health status, activity level). Furthermore, the investigators will explore the possible moderating role of individual differences in sociodemographic and disease-related characteristics and mediating role of self-efficacy and self-compassion for the hypothesised effect.

Patients recruited from the Department of Respiratory Medicine, Aarhus University Hospital, will be randomized to participate in either an 8-week MBCT program as an add-on to the already established pulmonary rehabilitation program (intervention group) or pulmonary rehabilitation only (treatment-as-usual). Questionnaires assessing outcomes, mediators and moderators will be completed before, during, and after the intervention as well as at a 3 and 6 mo. follow-up.

This study will be one of the first to test the efficacy of MBCT in COPD, bringing attention to a patient group that is relatively ignored by the public as well as in the health psychological empirical literature.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • severe to very severe COPD
  • motivated to participate in pulmonary rehabilitation
  • sufficient mobility to attend pulmonary rehabilitation

Exclusion Criteria:

  • certain comorbidities (e.g. unstable coronary complications, psychiatric illness)
  • severe cognitive disability (e.g. dementia)
  • inability to speak Danish
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02042976

Contacts
Contact: Anders L Ottesen, MD +45 78462091 andeotte@rm.dk

Locations
Denmark
Aarhus University Hospital Recruiting
Aarhus, Aarhus C, Denmark, 8000
Principal Investigator: Ingeborg Farver-Vestergaard, MSc         
Sponsors and Collaborators
University of Aarhus
Aarhus University Hospital
Investigators
Study Director: Robert Zachariae, MSc DMSci Aarhus University Hospital
  More Information

Publications:
Responsible Party: University of Aarhus
ClinicalTrials.gov Identifier: NCT02042976     History of Changes
Other Study ID Numbers: MBCT-KOL-2014
Study First Received: January 17, 2014
Last Updated: February 3, 2014
Health Authority: Denmark: Central Denmark Region Committees on Health Research

Keywords provided by University of Aarhus:
Chronic obstructive pulmonary disease (COPD)
Mindfulness-based cognitive therapy (MBCT)
Behavioural intervention
Quality-of-life
Anxiety
Depression
Physical health status

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Bronchitis
Bronchitis, Chronic
Emphysema
Pulmonary Emphysema
Lung Diseases
Respiration Disorders
Lung Diseases, Obstructive
Bronchial Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Pathologic Processes

ClinicalTrials.gov processed this record on July 22, 2014